07/07/2016Eurobiomed

i2a has been awarded with the Pass French Tech

2a is an In Vitro Diagnostics company that develops, manufactures, and sells innovative systems and solutions dedicated to microbiology. The mission of this company is to fight against infectious diseases. i2a has been involved in this mission and has been awarded with the Pass French Tech label.

i2a is now part of the prestigious circle of elite French technology companies with high potential for growth and development. La French Tech was founded in 2013, and it consists of a large collective mobilized drive growth and business development of French digital startups. The Pass French Tech is a tailor-made service developed by La French Tech, launched in March 2014 for companies that are experiencing a hyper-growth phase. The purpose of this program is to amplify the development of those companies. It allows them to reach target services for financing, international market penetration, innovation, business development, and company exposure. Hence, every selected company has a privileged access to services provided by major public economic operators (DGE, Bpifrance, Business France, Coface, Inpi) and private ones (AFPC, AFIC).

The jury of La French Tech for Montpellier Méditerranée Métropole selected only 4 companies, one of which was i2a, for the know-how and the unique innovation in the field of microbiology, the strong growth and the international development potential of i2a have been recognized and rewarded.

“We are very proud to receive this label that rewards our involvement for innovation and our strategy of development. The Pass French Tech will encourage and accelerate the recognition and the brand image of our company, in France as well as in the international market, to stakeholders such as financial and institutional or industrial partners."

Christian CUREL, CEO of i2a

About i2a
Founded in 1988, i2a has developed and distributed a large range of solutions, including instruments, software, reagents and consumables dedicated to microbiology market and more specifically for bacteriology operators. i2a’s solutions are designed for diagnostic professionals from public sector (public hospitals) or private sectors (clinical and reference labs). Based in Montpellier, France, i2a has more than 100 employees and has incorporated two North-American subsidiaries in Canada since 2003 and in the USA since 2014.